Literature DB >> 30519962

Hypertrophic obstructive cardiomyopathy and mitral regurgitation in Libman-Sacks endocarditis.

Go Yamashita1, Naoki Kanemitsu2, Yasuaki Nakashima3, Takehiko Matsuo2, Takeichiro Nakane2, Masanori Honda2, Hitoshi Okabayashi2.   

Abstract

Hypertrophic obstructive cardiomyopathy in Libman-Sacks endocarditis is quite rare and the correct etiological relationship between them is unknown. Some changes may cause a secondary disorganization of the ordinary muscle structure, making a disarray pattern with irregular interwoven myocyte fibers. This case report describes one of the first cases of ventricular septal myectomy and mitral valve replacement for hypertrophic obstructive cardiomyopathy and mitral valve regurgitation associated with Libman-Sacks endocarditis.

Entities:  

Keywords:  Hypertrophic obstructive cardiomyopathy; Libman–Sacks Endocarditis; Mitral regurgitation

Mesh：

Year:  2018        PMID： 30519962     DOI： 10.1007/s11748-018-1042-7

Source DB:  PubMed          Journal:  Gen Thorac Cardiovasc Surg        ISSN： 1863-6705


  9 in total

1.  Hypertrophic cardiomyopathy in systemic lupus erythematosus.

Authors:  G P Anastasiadis; I Moyssakis; K Boki; M Kyriakidis
Journal:  Mayo Clin Proc       Date:  2001-01       Impact factor: 7.616

2.  [A case of systemic lupus erythematosus associated with hypertrophic cardiomyopathy].

Authors:  Takuya Kotani; Tohru Takeuchi; Michiyo Sakamoto; Yoshiko Kawasaki; Suzue Hirano; Yoko Tabushi; Maki Kagitani; Shigeki Makino; Fumio Terasaki; Toshiaki Hanafusa
Journal:  Nihon Rinsho Meneki Gakkai Kaishi       Date:  2005-12

3.  An echocardiographic study of valvular heart disease associated with systemic lupus erythematosus.

Authors:  C A Roldan; B K Shively; M H Crawford
Journal:  N Engl J Med       Date:  1996-11-07       Impact factor: 91.245

4.  Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention.

Authors:  Barry J Maron; Jeffrey A Towbin; Gaetano Thiene; Charles Antzelevitch; Domenico Corrado; Donna Arnett; Arthur J Moss; Christine E Seidman; James B Young
Journal:  Circulation       Date:  2006-03-27       Impact factor: 29.690

5.  Libman-Sacks Endocarditis in a Patient With Antiphospholipid Syndrome.

Authors:  Kunal D Kotkar; Sameh M Said
Journal:  Ann Thorac Surg       Date:  2016-07       Impact factor: 4.330

Review 6.  Cardiovascular manifestations of systemic lupus erythematosus.

Authors:  N E Doherty; R J Siegel
Journal:  Am Heart J       Date:  1985-12       Impact factor: 4.749

Review 7.  The MOGE(S) classification of cardiomyopathy for clinicians.

Authors:  Eloisa Arbustini; Navneet Narula; Luigi Tavazzi; Alessandra Serio; Maurizia Grasso; Valentina Favalli; Riccardo Bellazzi; Jamil A Tajik; Robert O Bonow; Robert D Bonow; Valentin Fuster; Jagat Narula
Journal:  J Am Coll Cardiol       Date:  2014-07-22       Impact factor: 24.094

8.  Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases.

Authors:  Perry Elliott; Bert Andersson; Eloisa Arbustini; Zofia Bilinska; Franco Cecchi; Philippe Charron; Olivier Dubourg; Uwe Kühl; Bernhard Maisch; William J McKenna; Lorenzo Monserrat; Sabine Pankuweit; Claudio Rapezzi; Petar Seferovic; Luigi Tavazzi; Andre Keren
Journal:  Eur Heart J       Date:  2007-10-04       Impact factor: 29.983

9.  Hypertrophic cardiomyopathy in systemic lupus erythematosus and "lupus-like" disease. Chance association? A report of 2 cases.

Authors:  R A Asherson; D Ames; J Coltart; C Byrne; G R Hughes
Journal:  J Rheumatol       Date:  1992-12       Impact factor: 4.666
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.